Cidara Therapeutics Liabilities 2024

Cidara Therapeutics Aktienanalyse

What does Cidara Therapeutics do?

Cidara Therapeutics Inc. is a biopharmaceutical company specializing in the development and marketing of innovative therapies for serious infectious diseases. The company was founded in 2013 and is headquartered in San Diego, California. The founders of Cidara Therapeutics Inc. aimed to develop a new class of antifungal drugs that are particularly effective against fungal infections. The underlying technology is based on the Cloudbreak® peptide platform, which allows for the production of drugs with improved efficacy and safety. The company also has research collaborations with leading scientists in the field of infectious diseases to advance the development of antibody therapy, vaccines, and other drugs. The business model of Cidara Therapeutics Inc. focuses on the development and marketing of innovative therapeutic products for unmet medical needs. The company has divided its products into three divisions: infectious diseases, oncology, and immunology. Cidara's product pipeline includes several innovative drugs that have shown efficacy in phase I and phase II clinical trials. The infectious diseases division initially focuses on the development of antifungal drugs for the treatment of Candida infections, which can be life-threatening for people with weakened immune systems. Cidara Therapeutics Inc. has already successfully completed a clinical trial for its lead product, rezafungin. Rezafungin is a long-acting, liposomal antifungal drug that enables a single dose for effective treatment of Candida infections. The oncology division focuses on the development of innovative immunotherapies that use the body's immune system to attack cancer cells. Cidara Therapeutics Inc. utilizes the Cloudbreak® platform technology to develop new drugs that specifically target certain types of cancer. The lead product in this pipeline is CD371, a monoclonal antibody targeting acute myeloid leukemia (AML). The immunology division focuses on developing therapeutics for autoimmune diseases that bring the body's immune system under medical control to reduce inflammation and damage to target organs. The lead product in this product line is Cloudbreak® immunomodulators, which specifically regulate immune responses and combat inflammation. Overall, Cidara Therapeutics Inc. is a promising company that focuses on the development and marketing of innovative drugs for high unmet medical needs. The company's diverse and well-balanced product pipelines in the areas of infectious diseases, oncology, and immunology demonstrate the great potential of this business model. With the advanced Cloudbreak® technology and the dedicated team, Cidara Therapeutics Inc. has the potential to take a global leadership role in drug development and save lives. Cidara Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Cidara Therapeutics's Liabilities

Cidara Therapeutics's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Cidara Therapeutics's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Cidara Therapeutics's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Cidara Therapeutics's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Cidara Therapeutics’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Cidara Therapeutics Stock

What is the level of liabilities of Cidara Therapeutics this year?

Cidara Therapeutics has a debt balance of 75.24 M USD this year.

What were the liabilities of Cidara Therapeutics compared to the previous year?

The liabilities of Cidara Therapeutics have increased by 21.5% increased compared to the previous year.

What are the consequences of high debt for investors of Cidara Therapeutics?

High liabilities can pose a risk for investors of Cidara Therapeutics, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Cidara Therapeutics?

Low liabilities mean that Cidara Therapeutics has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Cidara Therapeutics affect the company?

An increase in liabilities of Cidara Therapeutics can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Cidara Therapeutics affect the company?

A decrease in the liabilities of Cidara Therapeutics can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Cidara Therapeutics?

Some factors that can influence the liabilities of Cidara Therapeutics include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Cidara Therapeutics so important for investors?

The liabilities of Cidara Therapeutics are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Cidara Therapeutics take to modify the liabilities?

To change its liabilities, Cidara Therapeutics can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Cidara Therapeutics pay?

Over the past 12 months, Cidara Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cidara Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Cidara Therapeutics?

The current dividend yield of Cidara Therapeutics is .

When does Cidara Therapeutics pay dividends?

Cidara Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Cidara Therapeutics?

Cidara Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Cidara Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Cidara Therapeutics located?

Cidara Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Cidara Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cidara Therapeutics from 6/17/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/17/2024.

When did Cidara Therapeutics pay the last dividend?

The last dividend was paid out on 6/17/2024.

What was the dividend of Cidara Therapeutics in the year 2023?

In the year 2023, Cidara Therapeutics distributed 0 USD as dividends.

In which currency does Cidara Therapeutics pay out the dividend?

The dividends of Cidara Therapeutics are distributed in USD.